For Ki-67 variation group, there was no significant difference in survival time between NET and NEC groups, between synchronous and metachronous metastatic tumor groups, between Ki-67 index up-regulated and down-regulated groups (Fig. 5g-i). This evidence concerns the gene MKI67 and metastatic neoplasm.